Literature DB >> 10432161

A randomized trial of 72- versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy.

A G Matlow1, I Kitai, H Kirpalani, N H Chapman, M Corey, M Perlman, P Pencharz, S Jewell, C Phillips-Gordon, R Summerbell, E L Ford-Jones.   

Abstract

OBJECTIVE: To compare the microbial contamination rate of infusate in the intravenous tubing of newborns receiving lipid therapy, replacing the intravenous delivery system at 72-hour versus 24-hour intervals.
DESIGN: Infants requiring intravenous lipid therapy were randomly assigned to have intravenous sets changed on a 72- or a 24-hour schedule, in a 3:1 ratio, in order to compare the infusate contamination rates in an equivalent number of tubing sets.
SETTING: A 35-bed, teaching, referral, neonatal intensive-care unit (NICU). PARTICIPANTS: All neonates admitted to the NICU for whom intravenous lipid was ordered.
METHODS: Patients were randomized in pharmacy, on receipt of the order for intravenous lipid therapy, to either 72- or 24-hour administration set changes, and followed until 1 week after discontinuation of lipids or discharge from the NICU. Microbial contamination of the infusate was assessed in both groups at the time of administration set changes. Contamination rates were analyzed separately for the lipid and amino acid-glucose tubing sets. Patient charts were reviewed for clinical and epidemiological data, including birth weight, gestational age, gender, age at start of lipid therapy, duration of parenteral nutrition, and type of intravenous access.
RESULTS: During the study period, 1,101 and 1,112 sets were sampled in the 72- and 24-hour groups, respectively. Microbial contamination rates were higher in the 72-hour group than the 24-hour group for lipid infusions (39/1,101 [3.54%] vs 15/1,112 [1.35%]; P=.001) and for amino acid infusions (12/1,093 [1.10%] vs 4/1,103 [0.36%]; P=.076). Logistic regression analysis controlling for birth weight, gestational age, and type of venous access showed that only the tubing change interval was significantly associated with lipid set contaminations (odds ratio, 2.69; P=.0013). The rate of blood cultures ordered was higher in the 72- versus the 24-hour group (6.11 vs 4.99 per 100 patient days of total parenteral nutrition; P=.017), and a higher proportion of infants randomized to the 72-hour group died (8% vs 4%; P=.05), although the excess deaths could not clearly be attributed to bacteremia.
CONCLUSION: Microbial contamination of infusion sets is significantly more frequent with 72- than with 24-hour set changes in neonates receiving lipid solutions. This may be associated with an increased mortality rate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432161     DOI: 10.1086/501657

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  8 in total

Review 1.  Does decreasing the frequency of changing intravenous administration sets (>24 h) increase the incidence of sepsis in neonates receiving total parenteral nutrition?

Authors:  Nevart Chirinian; Vibhuti Shah
Journal:  Paediatr Child Health       Date:  2012-11       Impact factor: 2.253

2.  Microbial Contamination of Neonatal Injectable Lipid Emulsions at 12 and 24 Hours' Infusion Time With Evaluation of Infection Control Measures.

Authors:  Eman A Omran; Faten F Eisa; Wafaa M K Bakr
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

Review 3.  Optimal timing for intravascular administration set replacement.

Authors:  Amanda J Ullman; Marie L Cooke; Donna Gillies; Nicole M Marsh; Azlina Daud; Matthew R McGrail; Elizabeth O'Riordan; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2013-09-15

4.  Catheter-related bloodstream infections in neonatal intensive care units.

Authors:  Jung Hyun Lee
Journal:  Korean J Pediatr       Date:  2011-09-30

5.  Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial).

Authors:  Claire M Rickard; Nicole M Marsh; Joan Webster; Nicole C Gavin; Matthew R McGrail; Emily Larsen; Amanda Corley; Debbie Long; John R Gowardman; Marghie Murgo; John F Fraser; Raymond J Chan; Marianne C Wallis; Jeanine Young; David McMillan; Li Zhang; Md Abu Choudhury; Nicholas Graves; E Geoffrey Playford
Journal:  BMJ Open       Date:  2015-02-03       Impact factor: 2.692

6.  Standardised neonatal parenteral nutrition formulations - Australasian neonatal parenteral nutrition consensus update 2017.

Authors:  Srinivas Bolisetty; David Osborn; Tim Schindler; John Sinn; Girish Deshpande; Chee Sing Wong; Susan E Jacobs; Nilkant Phad; Pramod Pharande; Rodney Tobiansky; Melissa Luig; Amit Trivedi; Joanne Mcintosh; Eszter Josza; Gillian Opie; Lyn Downe; Chad Andersen; Vineesh Bhatia; Prasanna Kumar; Katri Malinen; Pita Birch; Karen Simmer; Gemma McLeod; Suzanne Quader; Victor Samuel Rajadurai; Michael Patrick Hewson; Arun Nair; Megan Williams; Jing Xiao; Hari Ravindranathan; Roland Broadbent; Kei Lui
Journal:  BMC Pediatr       Date:  2020-02-08       Impact factor: 2.125

Review 7.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18

8.  Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012.

Authors:  Srinivas Bolisetty; David Osborn; John Sinn; Kei Lui
Journal:  BMC Pediatr       Date:  2014-02-18       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.